“As shelter-in-place orders are lifted, controlling the COVID-19 pandemic will depend on our ability to detect SARS-CoV-2 from a large number of samples with precision, reproducibility, and speed. To support this effort, we optimized our existing chemistries and developed SmartChip protocols that maximize the number of samples processed while minimizing costs. The work we have accomplished with bioSyntagma, plus their partners’ further development of diagnostic tests based on our work, will contribute to comprehensive and faster detection of COVID-19.”